Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypopigmented mycosis fungoides].

N Cordel1, A-B Duval-Modeste, Ph Courville

  • 1Clinique Dermatologique, CHU Charles Nicolle, Rouen.

Annales De Dermatologie Et De Venereologie
|July 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French national protocol for diagnosis and management of pemphigoid gestationis.

Annales de dermatologie et de venereologie·2026
Same author

Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Decision-making factors for the long-term topical treatment of mild-to-moderate plaque psoriasis: TEPPSO, a case-vignette study on clinical practice.

Annales de dermatologie et de venereologie·2022
Same author

IgA and IgG/IgA intercellular dermatosis: a clinicopathological case series of 15 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Efficacy of nivolumab in the treatment of metastatic cutaneous squamous cell carcinoma in a kidney-transplant patient with a history of allograft rejection.

Annales de dermatologie et de venereologie·2022
Same author

Updated French guidelines for the therapeutic management of bullous pemphigoid.

Annales de dermatologie et de venereologie·2021
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Hypopigmented mycosis fungoides, a rare skin condition, often affects individuals with darker skin tones and presents in childhood. Early diagnosis is crucial due to its slow progression, with treatments similar to early-stage mycosis fungoides.

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Hypopigmented mycosis fungoides is a rare variant of mycosis fungoides, first described in 1978.
  • Fewer than 100 cases have been documented globally.

Observation:

  • A case report details a 19-year-old African female with hypochromatic macules since age 9, diagnosed as hypopigmented mycosis fungoides.
  • This presentation highlights the early onset and diagnostic challenges of the condition.

Findings:

  • Hypopigmented mycosis fungoides predominantly affects individuals with darker skin (African or Asian origin) and often presents in pediatric cases.
  • The condition exhibits an indolent, slow-progressing course, leading to delayed diagnosis.
  • Differential diagnoses include vitiligo, achromate eczematides, and parapsoriasis; post-inflammatory depigmentation is an exclusion diagnosis.

Related Experiment Videos

Implications:

  • Early recognition and diagnosis are essential for effective management of hypopigmented mycosis fungoides.
  • Treatment aligns with classical Stage I mycosis fungoides, involving topical mechlorethamine, phototherapy, and topical corticosteroids.